A Mayo Clinic research group that previously evaluated Abbott's PCR-electrospray ionization mass spectrometry platform to broadly identify fungal infections has now published research demonstrating the system's ability to identify Mycobacterium species and M.
Researchers from the Mayo Clinic have demonstrated that Abbott's Plex-ID broad fungal assay is as good or in some cases better than culture-based methods for identifying fungal infections to the species level directly from respiratory specimens without prior knowledge of the offending orga
Scientists from Abbott and collaborating academic institutions have recently published a pair of studies demonstrating the ability of Abbott's Plex-ID platform to detect and identify in human samples a wide array of clinically relevant infectious organisms not picked up using mor
NEWPORT BEACH, Calif. – Scientists at Abbott subsidiary Ibis Biosciences have developed an assay to detect and genotype Borrelia burgdorferi, the bacterium responsible for causing Lyme disease in humans, using Abbott's Plex-ID microbial identification system.
Abbott said today that it has entered into an agreement with the University of North Texas Health Science Center to evaluate the company's Plex-ID instrument for use in analyzing human remains to support missing persons and human trafficking investigations.
Abbott's Plex-ID system, which combines PCR and mass spec analysis, will help authorities at state public health labs identify and characterize microorganisms in surveillance activities for infectious diseases, food safety analysis, and biodefense readiness.